Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Frontiers in Pharmacology|October 7, 2016
Adherence and Patients' Experiences with the Use of Capecitabine in Daily PracticeLonneke Timmers, Christel C L M Boons, Dirk Mangnus, et al.
Acta Oncologica (Stockholm, Sweden)|November 26, 2013
Adherence and patients' experiences with the use of oral anticancer agentsLonneke Timmers, Christel C L M Boons, Femke Kropff, et al.
Intensive Care Medicine|January 23, 2020
Machine learning for the prediction of sepsis: a systematic review and meta-analysis of diagnostic test accuracyLucas M Fleuren, Thomas L T Klausch, Charlotte L Zwager, et al.
Plos One|May 14, 2021
The prevalence of mental health problems in sub-Saharan adolescents: A systematic reviewAstrid Jörns-Presentati, Ann-Kathrin Napp, Anja S Dessauvagie, et al.
Global Mental Health (Cambridge, England)|January 25, 2021
The prevalence of mental health problems in sub-Saharan adolescents living with HIV: a systematic reviewA S Dessauvagie, A Jörns-Presentati, A-K Napp, et al.
British Journal of Clinical Pharmacology|December 29, 2021
Acute response to cholinergic challenge predicts long-term response to galantamine treatment in patients with Alzheimer's diseaseAnne Catrien Baakman, Carmen Gavan, Lotte van Doeselaar, et al.
European Journal of Drug Metabolism and Pharmacokinetics|September 13, 2024
Whole Body Physiologically Based Pharmacokinetic Model to Explain A Patient With Drug-Drug Interaction Between Voriconazole and FlucloxacillinHeshu Abdullah-Koolmees, Julia F van den Nieuwendijk, Simone M K Ten Hoope, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 4, 2023
Pharmacokinetics and pharmacodynamics of imatinib for optimal drug repurposing from cancer to COVID-19Nadia Baalbaki, Erik Duijvelaar, Medhat M Said, et al.
European Journal of Clinical Pharmacology|June 4, 2020
Response and Adherence to Nilotinib in Daily practice (RAND study): an in-depth observational study of chronic myeloid leukemia patients treated with nilotinibChristel C L M Boons, Lonneke Timmers, Jeroen J W M Janssen, et al.
Pageof 12